Todd Druley, MD, PhD established his career as a board-certified pediatric oncologist and tenured physician-scientist in molecular genomics at Washington University School of Medicine and St. Louis Children’s Hospital. Todd’s research program focused on improving molecular diagnostics for a variety of cancers, but specifically myeloid leukemia. He has published over 60 peer reviewed manuscripts, patented error-corrected NGS methods to improve AML MRD detection by next-generation sequencing and built clinical programs based on genetic predisposition to cancer. Prior to joining Mission Bio, he served as CMO of ArcherDX and ANGLE Biosciences since 2019.
Connect on LinkedIn
Return to Leadership Page